BIOFIRE® Respiratory 2.1 (RP2.1) Panel
The BIOFIRE RP2.1 Panel tests for 22 of the most likely respiratory targets, including viruses and bacteria, with results in about 45 minutes.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Great result
Respiratory pathogens
Easy fast and efficient
Review Date: 27 Jun 2023 | bioMérieux USA
Every lab should have this test offered!
Analysis of nasopharyngeal swab for the detection of relevant respiratory tract pathogen.
The Biofire Respiratory Panel 2.1 is a one stop test for all the relevant respiratory tract pathogen. It is quick, easy to use, and accurate!
Review Date: 17 Apr 2023 | bioMérieux USA
Easy setup and fast TAT!
Patient testing in hospital environment.
The BioFire Filmarray products are easy to use and each kit is standardized. If you know how to set up one type you pretty much know how to set up most of them. I do wish the kits came preassembled in easy grab and go pouches with one of each reagent and such in them instead of separated in big bags. Repeated opening/closing of the bags and hands in and out increases the risk of contamination. So, packaging could be simplified and streamlined, but otherwise we are very happy with the products.
Review Date: 17 Apr 2023 | bioMérieux USA
The BIOFIRE RP2.1 Panel helps clinicians quickly diagnose respiratory infections, which present with nearly indistinguishable symptoms. Respiratory infections can be caused by many viruses and bacteria—not just SARS-CoV-2 or influenza. The BIOFIRE RP2.1 Panel uses a molecular approach to accurately detect and identify the pathogens most commonly associated with respiratory infections.
- Detects and identifies 18 viral targets, including SARS-CoV-2, and 4 bacterial targets
- Results are available in about 45 minutes
- Available for use on the BIOFIRE® FILMARRAY® TORCH and the BIOFIRE® FILMARRAY® 2.0 systems
Bridging pandemic-associated antimicrobial stewardship gaps with diagnostics
Join Brian Raux, Medical Science Liaison at bioMérieux, in this webinar as he discusses the gaps in antimicrobial stewardship programs caused by the COVID-19 pandemic and how diagnostics can be leveraged to bridge those gaps.
During the webinar, Raux will cover how antimicrobial resistance has changed during the pandemic and how institutions can locally track and use their data. Raux will also explore the impact staffing shortages have had on the microbiology lab and how utilizing the syndromic approach can enable labs to do more with less.
Key learning objectives
- Realize the impact of rapid molecular diagnostics on antibiotic use
- Understand local antibiograms and growing resistance
- Explore the impact of syndromic testing and how it can address workforce shortages
Who should attend?
- Lab professionals: directors, supervisors, techs, etc. Clinicians, Pharmacists
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Rapid diagnostics combat unnecessary antimicrobial use in pulmonary disease management
Discover how a rapid diagnosis between viral and bacterial pulmonary infections can minimize antibiotic usage in critical care
Accelerating science with technology: The hero lab products you can’t live without
To recognize 25 years of accelerating science, we’re highlighting reviews on innovative technologies and your laboratory essentials
